Related Experiment Video

Updated: Aug 8, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 15, 2011

Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2

K Vehmeyer1, P Scheurich, H Eibl

  • 1Department of Internal Medicine, University of Göttingen, Federal Republic of Germany.

Cellular Immunology
|October 1, 1991
PubMed

Insights

Low-dose hexadecylphosphocholine (He-PC) enhances interferon-gamma (IFN-g) production in peripheral mononuclear cells (PMNC), acting as a costimulator for T-cell activation. This immunomodulatory compound requires interleukin-2 (IL-2) to be effective.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Peripheral mononuclear cells (PMNC) are crucial for immune responses.
  • T-cell activation involves key parameters like cytokine production and antigen expression.
  • Hexadecylphosphocholine (He-PC) is a compound with potential biological effects.

Purpose of the Study:

  • To investigate the immunomodulatory effects of low-dose hexadecylphosphocholine (He-PC) on normal peripheral mononuclear cells (PMNC).
  • To assess the impact of He-PC on T-cell activation markers, including interferon-gamma (IFN-g) production, interleukin-2 (IL-2) receptor expression, and HLA-DR antigen expression.

Main Methods:

  • PMNC cultures were treated with varying doses of He-PC.
  • IFN-g production was measured, with and without exogenous IL-2.
  • IL-2 receptor and HLA-DR antigen expression were analyzed using immunofluorescence.

Main Results:

  • He-PC dose-dependently enhanced IFN-g production in the presence of exogenous IL-2.
  • He-PC alone did not stimulate IFN-g production without IL-2.
  • He-PC stimulated IFN-g production with suboptimal phytohemagglutinin (PHA) and increased IL-2 receptor and HLA-DR expression.

Conclusions:

  • He-PC exhibits immunomodulatory activity by costimulating the IL-2-mediated T-cell activation process.
  • He-PC may possess in vivo immunomodulatory potential.
  • The findings suggest He-PC could be a valuable agent in modulating immune responses.

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 8, 2019

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.